Relx (LON:REL) Stock Crosses Above 200 Day Moving Average of $3,157.41

Relx Plc (LON:REL) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 3,157.41 ($39.31) and traded as high as GBX 3,377 ($42.04). Relx shares last traded at GBX 3,354 ($41.75), with a volume of 2,069,807 shares.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on REL shares. JPMorgan Chase & Co. upped their target price on shares of Relx from GBX 3,770 ($46.93) to GBX 4,100 ($51.04) and gave the stock an “overweight” rating in a research note on Friday, February 16th. Berenberg Bank downgraded shares of Relx to a “hold” rating and upped their target price for the stock from GBX 3,300 ($41.08) to GBX 3,500 ($43.57) in a research note on Friday, March 29th.

Relx Trading Up 0.4 %

The firm’s 50 day moving average price is GBX 3,384.05 and its 200-day moving average price is GBX 3,157.41. The stock has a market cap of £62.72 billion, a P/E ratio of 3,568.09, a P/E/G ratio of 3.63 and a beta of 0.46. The company has a debt-to-equity ratio of 188.92, a current ratio of 0.52 and a quick ratio of 0.45.

Relx Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, June 13th. Investors of record on Thursday, May 2nd will be given a dividend of GBX 41.80 ($0.52) per share. This is an increase from Relx’s previous dividend of $17.00. The ex-dividend date is Thursday, May 2nd. This represents a yield of 1.25%. Relx’s dividend payout ratio is 6,276.60%.

About Relx

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.